Evidence-Based Tobacco Cessation Strategies in Patients With Cancer

Not Applicable

Completed

• Conditions: Malignant Neoplasm

• Registration Number: NCT02211196
• Lead Sponsor: Wake Forest University Health Sciences

Brief Summary

This pilot clinical trial studies evidence-based tobacco cessation strategies in patients with cancer. Stop-smoking plans suggested by doctors may help patients with cancer quit smoking.

Detailed Description

PRIMARY OBJECTIVES:

I. To assess oncology providers' self-reported need for training on evidence-based tobacco cessation strategies and assess their level of interest in future training on evidence-based tobacco cessation strategies.

II. To test the feasibility of the implementation of evidence-based tobacco cessation strategies in community oncology clinics.

III. To test the feasibility of surveying community oncology patients after a clinic visit to assess provider behavior regarding screening and brief intervention for tobacco use.

OUTLINE:

Patients complete a survey over approximately 10-15 minutes related to their provider's cessation advice and assistance with quitting.

After completion of study, patients are followed up at 1 month.

Study Timeline

• Study Start: 2013-02
• Study First Submitted: 2014-08-05
• Study First Submitted QC: 2014-08-05
• Study First Posted: 2014-08-07
• Primary Completion: 2014-11
• Study Completion: 2014-11
• Status Verified: 2018-07
• Last Update Submitted: 2018-07-02
• Last Update Posted: 2018-07-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 377

Inclusion Criteria

• All patients with cancer who saw a provider will be eligible

Exclusion Criteria

• Having a nurse or lab visit only

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Percentage reporting they would be willing to participate in training on evidence-based tobacco cessation strategies	Up to 1 month	Will be estimated and 95% CI constructed.
Proportion of patients who report that their provider asked about tobacco use during their visit	Up to 1 month	These prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes. These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics.
Proportion of current smokers who report that their provider advised them to quit during their visit and provided tobacco-cessation strategies	Up to 1 month	These prevalences will be estimated at pre- and post-intervention, and 95% CIs calculated adjusting for the expected within-clinic correlation of patient outcomes. These outcomes will be analyzed further using a subject-specific modeling approach to account for the correlation that occurs due to patients being clustered within clinics.
Percentage of providers from the Piedmont Oncology Association (POA) reporting a need for training on evidence-based tobacco cessation strategies	Up to 1 month	Will be estimated and 95% confidence intervals (CI) constructed.
Percentage reporting feeling very confident in their ability to counsel smokers	Up to 1 month	Will be estimated and 95% CI constructed.
Proportion of oncology patients willing to complete a survey in an oncology clinic	Up to 1 month	Will be estimated and 95% CI constructed.

Trial Locations

Locations (1)

Comprehensive Cancer Center of Wake Forest University; 🇺🇸 Winston-Salem, North Carolina, United States